August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Naveen Pemmaraju: Results of A Novel CD123-ADC Pivekimab Sunirine for Patients with BPDCN
Aug 5, 2025, 10:28

Naveen Pemmaraju: Results of A Novel CD123-ADC Pivekimab Sunirine for Patients with BPDCN

Naveen Pemmaraju, Professor of the Department of Leukemia at MD Anderson Cancer Center, shared a post on LinkedIn:

“I was proud to be selected as one of 3 invited faculty to present at our recent MDACC Division of Cancer Medicine annual Best of ASCO Grand Rounds, moderated by Dr Bob Wolff.

I was able to present, on behalf of my co-authors, our work on Results of A Novel CD123-ADC Pivekimab Sunirine for patients with BPDCN.

Thank you, MD Anderson Cancer Center for your continued support and for this key opportunity to present our original work!”

Naveen Pemmaraju

More posts featuring Naveen Pemmaraju on OncoDaily.